Savolitinib for Treating Brain and Leptomeningeal Metastases in Non-Small Cell Lung Cancer: A Case Study - Top-Institutions - MDSpire

Savolitinib for Treating Brain and Leptomeningeal Metastases in Non-Small Cell Lung Cancer: A Case Study

  • By

  • Xuejiao Qi

  • Zhijiao Song

  • Junying He

  • Hui Bu

  • April 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Oncology
    • Neuro-Oncology
    • Molecular Diagnostics

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Thoracic Oncology
    • Neuro-Oncology
    • Targeted Therapy Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Neuro-Oncology
    • Clinical Trials

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Thoracic Oncology
    • Neuro-Oncology
    • Molecular Pathology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Thoracic Oncology
    • Neuro-Oncology
    • Precision Medicine

Original Source(s)

Savolitinib for Treating Brain and Leptomeningeal Metastases in Non-Small Cell Lung Cancer: A Case Study

  • by Xuejiao Qi, Zhijiao Song, Junying He, Hui Bu

  • April 24, 2026

Related Content

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation